US Patent Issued to ARENA PHARMACEUTICALS on Oct. 7 for "Compositions comprising PGI2-receptor agonists and processes for the preparation thereof" (California Inventor)

ALEXANDRIA, Va., Oct. 8 -- United States Patent no. 12,433,865, issued on Oct. 7, was assigned to ARENA PHARMACEUTICALS INC. (San Diego).

"Compositions comprising PGI2-receptor agonists and processes for the preparation thereof" was invented by John W. Adams (San Diego).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein in some embodiments are pharmaceutical compositions comprising a prostacyclin (PGI2) receptor agonist selected from 2-(((1r,4r)-4-(((4-chlorophenyl)(phenyl)carbamoyloxy)methyl)cyclohexyl)methoxy)acetic acid (Compound 1) and pharmaceutically acceptable salts, solvates, and hydrates thereof, as disclosed herein. In some embodiments the pharmaceutical compositions comprise a compound ...